SEC Comment Letter 0000000000-23-007524 to Microbot Medical Inc. (MBOT)
Microbot Medical Inc.
Date: July 14, 2023 · CIK: 0000883975 · Accession: 0000000000-23-007524
AI Filing Summary & Sentiment
File numbers found in text: 333-273207
Letter
United States securities and exchange commission logo July 14, 2023 Harel Gadot Chief Executive Officer, President and Chairman Microbot Medical Inc. 288 Grove Street, Suite 388 Braintree, MA 02184 Re:Microbot Medical Inc. Registration Statement on Form S-1 Filed July 11, 2023 File No. 333-273207 Dear Harel Gadot: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Joshua Gorsky at 202-551-7836 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Stephen E. Fox, Esq.
Show Raw Text
United States securities and exchange commission logo
July 14, 2023
Harel Gadot
Chief Executive Officer, President and Chairman
Microbot Medical Inc.
288 Grove Street, Suite 388
Braintree, MA 02184
Re:Microbot Medical Inc.
Registration Statement on Form S-1
Filed July 11, 2023
File No. 333-273207
Dear Harel Gadot:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Joshua Gorsky at 202-551-7836 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Stephen E. Fox, Esq.